Chapter 41: Oncological and Hematological Disorders

Oncological and Hematological Disorders establishes foundational cancer biology concepts including cellular transformation mechanisms, classification systems distinguishing between solid tumors and blood-based cancers, and the pathways through which malignant cells disseminate to distant sites via lymphatic channels, circulatory systems, and direct extension. The chapter presents standardized grading frameworks that assess cellular differentiation and staging protocols including the TNM classification system that determines disease extent and treatment planning. Diagnostic approaches encompassing tissue sampling methods, imaging technologies, and serological tumor markers enable early detection and treatment optimization. Major therapeutic modalities are explored in detail: surgical interventions ranging from preventive resection to palliative procedures, chemotherapy mechanisms and associated toxicities including bone marrow suppression and gastrointestinal complications, radiation therapy delivered through external beam or internal brachytherapy approaches, and hematopoietic stem cell transplantation with autologous, allogeneic, and syngeneic donor sources. The chapter systematically addresses specific malignancies including acute and chronic leukemias with characteristic laboratory abnormalities and infection management strategies, Hodgkin and non-Hodgkin lymphomas with prognostic factors and treatment approaches, and multiple myeloma emphasizing bone disease management and renal preservation. Reproductive system cancers including cervical, endometrial, ovarian, breast, testicular, and prostate malignancies are analyzed with epidemiological risk factors, clinical presentations, surgical and adjuvant treatment options, and survivorship considerations. The chapter concludes by examining acute oncological emergencies such as tumor lysis syndrome with hyperuricemia and electrolyte derangements, superior vena cava syndrome from mediastinal obstruction, spinal cord compression requiring urgent intervention, and disseminated intravascular coagulation. Integrated nursing interventions address infection prevention in immunocompromised patients, hemorrhage precautions for thrombocytopenic individuals, management of chemotherapy-induced toxicities, and comprehensive psychosocial support throughout the cancer trajectory.